Mohamed El‐Tanani

Ras al-Khaimah Medical and Health Sciences University

4本站收录论文

12这些论文的被引

2本站 h 指数

12合作者

作者编号 A5076962976 · ORCID 0000-0002-4735-5445。统计只算本站收录的论文。

发表的论文4 篇，按出版时间

1
Tirzepatide data: safety first is safety always!Expert Opinion on Drug Safety20260
2
Modulating Metabolic Health and Physiological Functions: Advances in Dietary Interventions Targeting Gut MicrobiotaTherapeutics and Clinical Risk Management20256
3
Unraveling the safety and efficacy of semaglutide for people living with HIV and metabolic co-morbiditiesExpert Opinion on Drug Safety20240
4
Gastrointestinal adverse events associated with immune checkpoint inhibitors: a pharmacovigilance analysis of the EudraVigilance and VigiAccess databasesExpert Opinion on Drug Safety20246

按月发文

逐年被引

合作者

Syed Arman Rabbani3 篇 Manfredi Rizzo3 篇 Miodrag Janić2 篇 Andrej Janež2 篇 Dimitrios Patoulias1 篇 Imran Rashid Rangraze1 篇 Viviana Maggio1 篇 Paschalis Karakasis1 篇 Atul Khurana1 篇 Mandeep Kumar Arora1 篇 Shrestha Sharma1 篇 Sathvik Belagodu Sridhar1 篇

研究主题和期刊

Expert Opinion on Drug Safety3 Therapeutics and Clinical Risk Management1